DOLBY LABORATORIES, INC. financials

  1. Home
  2. Financials
  3. DLB
DLB CIK 0001308547

Source: EDGAR filings · Built 2026-06-04T02:25:30Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 435.85M 297.25M 336.74M 270.65M 393.30M 277.50M
EBITDA 352.79M 333.88M 298.31M 295.07M 440.25M 309.62M
Working Capital 950.47M 776.58M 1.07B 1.03B 1.44B 1.28B
Net Debt -663.01M -435.06M -694.72M -569.18M -1.15B -990.74M
Gross Margin 88.13% 88.97% 88.26% 88.73% 89.85% 87.39%
Operating Margin 19.64% 20.28% 16.60% 16.48% 26.88% 18.83%
Net Margin 18.90% 20.56% 15.44% 14.68% 24.21% 19.91%
Return on Equity (ROE) 9.72% 10.57% 8.52% 8.20% 11.94% 9.51%
Return on Assets (ROA) 7.90% 8.42% 6.73% 6.84% 9.99% 7.93%
Current Ratio 3.17× 2.86× 3.52× 4.72× 5.58× 5.79×
Debt-to-Equity 0.01× 0.02× 0.02× 0.02× 0.03× 0.03×
Effective Tax Rate 15.48% 15.41% 19.36% 14.58% 10.35% 3.38%
Cash Conversion Ratio 1.85× 1.25× 1.83× 1.73× 1.44× 1.49×
Accruals Ratio -0.07× -0.02× -0.06× -0.05× -0.04× -0.04×
SBC % of Revenue 9.53% 9.41% 9.12% 9.17% 7.78% 7.46%
CapEx Coverage 12.99× 10.91× 12.10× 6.65× 8.22× 5.18×
Free Cash Flow Per Share $4.47 $3.05 $3.45 $2.65 $3.76 $2.70

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 27.63× 28.11× 38.66× 35.99× 31.13× 28.88×
P/FCF 16.19× 24.76× 23.00× 24.55× 24.60× 24.11×
FCF Yield 6.18% 4.04% 4.35% 4.07% 4.07% 4.15%
EV / EBITDA 18.12× 20.74× 23.64× 20.59× 19.36× 18.41×
P/S 5.23× 5.78× 5.96× 5.30× 7.55× 5.76×
P/B 2.69× 2.97× 3.29× 2.96× 3.72× 2.75×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 1.35B 1.27B 1.30B 1.25B 1.28B 1.16B
Revenues — — — — 1.28B 1.16B
Cost of Revenue 160.13M 140.50M 152.57M 141.36M 130.03M 146.50M
Gross Profit 1.19B 1.13B 1.15B 1.11B 1.15B 1.02B
Research and Development Expense 261.79M 263.66M 271.52M 261.17M 253.64M 239.04M
Operating Expenses 924.04M 874.90M 931.42M 905.83M 806.84M 796.55M
Operating Income (Loss) 264.96M 258.33M 215.75M 206.60M 344.39M 218.74M
Income Tax Expense (Benefit) 46.99M 48.16M 48.41M 31.38M 36.69M 8.10M
Net Income (Loss) Attributable to Parent 255.02M 261.82M 200.66M 184.09M 310.23M 231.36M
Earnings Per Share, Basic $2.66 $2.74 $2.10 $1.84 $3.07 $2.30
Weighted Average Number of Shares Outstanding, Basic 95.87M 95.54M 95.77M 99.99M 101.19M 100.56M
Earnings Per Share, Diluted $2.62 $2.69 $2.05 $1.81 $2.97 $2.25
Weighted Average Number of Shares Outstanding, Diluted 97.48M 97.33M 97.73M 101.98M 104.62M 102.94M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 701.89M 482.05M 745.36M 620.13M 1.23B 1.07B
Assets, Current 1.39B 1.19B 1.49B 1.31B 1.76B 1.55B
Assets 3.23B 3.11B 2.98B 2.69B 3.11B 2.92B
Liabilities, Current 437.79M 417.84M 422.23M 277.52M 315.72M 267.11M
Liabilities 595.81M 623.03M 607.58M 438.53M 501.45M 478.92M
Stockholders' Equity Attributable to Parent 2.62B 2.48B 2.36B 2.25B 2.60B 2.43B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 472.20M 327.25M 367.08M 318.58M 447.75M 343.85M
Payments to Acquire Property, Plant, and Equipment 36.35M 30.01M 30.34M 47.93M 54.45M 66.35M
Net Cash Provided by (Used in) Investing Activities -10.59M -286.29M 54.21M -295.94M -44.91M 134.37M
Payments for Repurchase of Common Stock 124.99M 160.00M 149.28M 530.49M 245.86M 173.74M
Net Cash Provided by (Used in) Financing Activities -247.24M -287.81M -236.81M -610.56M -252.51M -207.78M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (DLB CIK 0001308547), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

M

Macy's, Inc.

TITN

TITAN MACHINERY INC.

COLB

COLUMBIA BANKING SYSTEM, INC.